Beranda › Kanker Prostat › New Hampshire
Uji klinis Kanker Prostat di New Hampshire
7 studi untuk Kanker Prostat mencari peserta di lokasi di New Hampshire.
Teks studi resmi (Bahasa Inggris)
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- New Hampshire Oncology Hematology PA-Concord, Concord
- Solinsky Center for Cancer Care, Manchester
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 40 hingga 75 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05334069The SUGAR Study; SBRT and Relugolix) for Prostate Cancer
- Dartmouth-Hitchcock Medical Center, Lebanon
Menerima pesertaFase 2
Usia 18 ke atas · Pria · Diperbarui 14 Sep 2026 · NCT06111781Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
- Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center, Lebanon
Menerima pesertaFase 3
Usia 18 ke atas · Pria · Diperbarui 10 Sep 2026 · NCT05946213Telmisartan in Prostate Cancer
- Dartmouth Health, Lebanon
Menerima pesertaFase 1
Usia 18 ke atas · Pria · Diperbarui 22 Jul 2026 · NCT06168487Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
- Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center, Lebanon
Menerima pesertaFase 3
Usia 18 ke atas · Pria · Diperbarui 14 Jul 2026 · NCT06592924Microendoscopic EI Sensing for Real-time Intraoperative Surgical Margin Assessment
- Dartmouth-Hitchcock Medical Center, Lebanon
Menerima pesertaStudi observasional
Usia 18 ke atas · Pria · Diperbarui 7 Apr 2026 · NCT06039085Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
- New Hampshire Oncology Hematology PA-Concord, Concord
- Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center, Lebanon
- Solinsky Center for Cancer Care, Manchester
Menerima pesertaFase 3
Usia 18 ke atas · Pria · Diperbarui 11 Sep 2025 · NCT03678025Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.